Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Role of predictive markers in personalised cancer treatment

Prof Ken O'Byrne - St James's Hospital, Dublin, Ireland
Role of predictive markers in personalised cancer treatment ( Prof Ken O'Byrne - St James's Hospital, Dublin, Ireland )
11 Mar 2011

Maintenance treatment for advanced non-small cell lung cancer

Prof Filippo de Marinis - Azienda Ospedaliera San Camillo Forlanini, Rome, Italy
Maintenance treatment for advanced non-small cell lung cancer ( Prof Filippo de Marinis - Azienda Ospedaliera San Camillo Forlanini, Rome, Italy )
10 Mar 2011

Targeted maintenance therapies for advanced non-small cell lung cancer

Dr Cesare Gridelli - S.G. Moscati Hospital, Avellino, Italy
Targeted maintenance therapies for advanced non-small cell lung cancer ( Dr Cesare Gridelli - S.G. Moscati Hospital, Avellino, Italy )
10 Mar 2011

Optimal treatment of multiple myeloma

Prof Meletios Dimopoulos, Prof Hermann Einsele, Prof Mario Boccadoro, Dr Maria-Victoria Mateos
Optimal treatment of multiple myeloma ( Prof Meletios Dimopoulos, Prof Hermann Einsele, Prof Mario Boccadoro, Dr Maria-Victoria Mateos )
28 Feb 2011

Key advances in the treatment of lymphoma from ASH 2010

Prof Mathias Rummel, Dr Umberto Vitolo, Prof Johannes Drach, Prof Christian Buske, Prof Owen O'Connor
Key advances in the treatment of lymphoma from ASH 2010 ( Prof Mathias Rummel, Dr Umberto Vitolo, Prof Johannes Drach, Prof Christian Buske, Prof Owen O'Connor )
28 Feb 2011

Changing the paradigm in frontline CML therapy

Prof Giuseppe Saglio - University of Turin, Italy; Dr Delphine Rea - Saint Louis Hospital, Paris; Jan Geissler - Co-Founder, CML Advocates Network
Changing the paradigm in frontline CML therapy ( Prof Giuseppe Saglio - University of Turin, Italy; Dr Delphine Rea - Saint Louis Hospital, Paris; Jan Geissler - Co-Founder, CML Advocates Network )
21 Feb 2011

Key lymphoma research from ASH 2010

Prof Wyndham Wilson - National Cancer Institute, Maryland, USA
Key lymphoma research from ASH 2010 ( Prof Wyndham Wilson - National Cancer Institute, Maryland, USA )
18 Feb 2011

The DASISION chronic myeloid leukaemia trial

Dr Neil Shah - University of California, San Francisco, USA
The DASISION chronic myeloid leukaemia trial ( Dr Neil Shah - University of California, San Francisco, USA )
18 Feb 2011

Administration of bortezomib in multiple myeloma patients

Prof Philippe Moreau - Centre Hospitalier Universitaire de Nantes, France
Administration of bortezomib in multiple myeloma patients ( Prof Philippe Moreau - Centre Hospitalier Universitaire de Nantes, France )
18 Feb 2011

Signalling pathways as a target for cancer therapies

Prof Mariann Bienz - MRC Laboratory of Molecular Biology, Cambridge, UK
Signalling pathways as a target for cancer therapies ( Prof Mariann Bienz - MRC Laboratory of Molecular Biology, Cambridge, UK )
14 Feb 2011

Tumour immunology and combined immunotherapies

Prof Ignacio Melero - University of Navarra, Pamplona, Spain
Tumour immunology and combined immunotherapies ( Prof Ignacio Melero - University of Navarra, Pamplona, Spain )
2 Feb 2011

Molecular chaperones: cancer dependence and druggability

Prof Paul Workman - The Institute of Cancer Research, Sutton, UK
Molecular chaperones: cancer dependence and druggability ( Prof Paul Workman - The Institute of Cancer Research, Sutton, UK )
19 Jan 2011